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Sepkovictt
Critical toamoredefinitivehumanhealthassessmentofthepotentialhealthrisksfromexposuretocomplexmixtures
inindoorair istheneed foramoredefinitiveclinical measureandetiologyofthehelatheffectsofcomplexmixtures. This
panel overview highlightssixoftheeight presentations oftheconferencepanel discussion andfeaturesanumberofthe
major topical areas ofindoor airconcern. W. G. Meggs assessedclinical research priorities with primary focuson the
roleofvolatileorganicchemicals inhumanhealth, recognizingtheareaswheredefinitivedataarelacking. By recogniz-
ingmany typesofchemical sensitivity, itmay bepossibletodesign studiesthatcanilluminatethemechanismsby which
chemical exposure may causedisease. Thecritically important topic ofmultiplechemicalsensitivity wasdiscussedbyN.
A. Ashford, whoidentified fourhighriskgroupsanddefinedthedemographicsofthesegroups. P. A. Schulteaddress-
edthe issueofbiological markersofsusceptibility withspecificconsiderations ofbothm ethodologia andsocietal aspects
that may beoperative in theability todetectinnate orinbornedifferencesbetween individualsand populations. Three
casestudies werereviewed. H. Andersondiscussed thepastandpresentprioritiesfromapublichealthperspective, focusing
onthoseissuesdealingwithexposurestoenvironmentaltobaccosmokeandformaldehydeoff-gassingfrommaterialsused
inmobile homeconstruction. J.J. Osbornedescribedseveralcasestudiesinvolvingwoodsmokeexposuretochildren, with
emphasis onthesignificantly greater occurrenceofchronicrespiratory symptomsandacutechestillnessforchildrenfrom
homes heated withwoodburningstoves. D. W. Sepkovicfocusedonthe useofaspecific nicotinemetabolite, cotinine, as
a biomarker ofenvironmental tobacco smokeuptake incontrolled studies.
Introduction
Reports of illnesses believed to be related to indoor air en-
vironments have increaseddramatically overthe pastdecade. In-
doorair may bepollutedby ahostofchemical and microbial tox-
insdepending onparticlesize, airexchange rates, byparticles in-
filtrating fromoutdoors, aswell as poor indoorairquality aris-
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ing frominadequatedesign, operation, andmaintenanceofven-
tilation and filtration systems.
Both chemical andbiological agents in complex mixtures in
indoorairhavebeenreportedtocausespecificillnessesandhave
raised questions regarding potential acute and chronic health
risks. A broad spectrumofcomplaints inofficeenvironments,
often referred to as "sick building syndrome;' has been char-
acterizedby frequency ofirritative symptomsoftheeyes, throat
and lowerairways, skinreactions, nonspecific hypersensitivity,
mental fatigue, headache, nausea, and dizziness. The term
"multiplechemical sensitivity" (MCS)hasdeveloped as acon-
troversial termdescribingavarietyofsymptomsassociated with
exposure to indoor airpollution.
Thereisacknowledgeddifficultyindistinguishingbetweensen-
sitivityresultingfromindoorairexposuretochemicalsandsen-
sitivitythatmayarisefrombacteria,mites,foods,orallergenssuch
as dust. Additionally, the role of "adaptation" in chemical or
bacterialsensitivityiscurrentlynotwellcharacterized, butmay
representdevelopedtoleranceunderexposureconditions.HENRY ETAL.
Itisbroadlyacknowledged that a morerigorouscharacteriza-
tion of the agents in indoor air complex mixtures as well as a
moredefinitiveclinical measureandetiology oftheirhealth ef-
fects are all critical for human health assessment. This Panel
Overview highlights six of the eight presentations of the
Workshop Panel Discussion and features anumberofthemajor
topical areas ofindoor air concern: the role ofvolatile organic
chemicals (VOCs) inhumanhealth; multiplechemical sensitivi-
ty, biological markers ofsusceptibility, and three case studies
dealing with resolution ofindoor air exposures andpriorities in
Wisconsin, exposure ofchildren to wood smoke, andthe useof
a specific biomarker to quantitate exposure to environmental
tobacco smoke.
Clinical Research Priorities: VOCs in
Human Health
Forthe past40 years or so, claimshavebeenmadethatVOCs
found inindoorairplay aroleindisease processesrangingfrom
asthma to schizophrenia. Data are nowavailable on exposure to
VOCs (1-3), but scientificdocumentation ofthe rolethese com-
pounds play inhumanhealth is atthis timeinadequate. Certainly,
the type ofdefinitive datathatestablishes a consensus islacking.
It is important to extrapolate our current knowledge about the
role of chemical exposures in human health to determine
research priorities.
Criteria forselecting fruitful areas forinvestigating a role for
VOCs in human health aregiven inTable 1. Epidemiologic data
documentingincreasing incidencesofcertaindisorders in recent
years, particularly iftheincreases are in industrialized nations
while sparseinprimitivecultures, suggestpossibleenvironmen-
tal factors. Diseases that canbe induced by exposure toorganic
chemicals such aspharmaceuticals andchemicalsoccurring in
foods should be studied with regard toVOCs. Ifthere areanimal
models of a disease in which chemical exposures induce the
disease or ifthere are case reports andanecdotal data linking a
disease to chemical inhalants, then this disease should be in-
vestigated for a role for VOCs. Ifadisease meets several ofthe
criteriagiven in Table 1, then specialemphasis should begiven
for study. Areas ofparticular concern are autoimmunediseases,
hypersensitivity disorders, and psychiatric illnesses.
Autoimmunediseases areknown tobecausedbyenvironmen-
tal chemicals in some patients (4,5). It is known that phar-
maceuticals can causeautoimmunehemolyticanemia(6), drug-
induced lupus (7), andotherautoimmunediseases. Hydrazine,
an organic solvent, similar to hydralazine, which is an an-
tihypertensive associated with lupus, can cause alupuslike syn-
drome from occupational exposureviainhalation (8). Other en-
vironmental chemicals, for example, an amino acid analogue
found in alfalfa sprouts (9), can induce lupus. If a person de-
velops anautoimmunedisease, thefirstquestionheorsheisask-
Table 1. Criteria for prioritizing clinical research on
volatile organic chemicals.
Diseases with increasing incidence in industrial societies
Diseases known to be induced by exposure to organic chemicals
such as pharmaceuticals andchemicals occurring in foods
Diseases in animal models in which chemical exposures induce the disease
Diseases with case reports andanecdotal data supporting a role for volatile
organic compounds
Table 2. Categories ofxenobiotics that induce hypersensitivity diseases.
Sensitizers
Environmental adjuvants
End-organ inducers
edby aclinician is iftheyaretakingany medications, and ifso,
thesearediscontinued asthepossiblecauseoftheautoimmune
processwith inmanycasesacurativeoutcome. Ifnomedications
are being taken, the autoimmune process is described as
"idiopathic" and treated with medications that are usually not
curative. Weneedtodeterminetheextenttowhichenvironmental
chemicals, in particular the VOCs, may be causative in some
cases of autoimmunity. If it can be established that inhaled
chemicals inthe indoorairplay aroleinautoimmunity, clinical
practice needstobebroadened to includeanassessmentofnon-
pharmaceutical exposures to organic chemicals.
Another area of concern is the role VOCs may play in hy-
persensitivity disorders. There are three ways in which a
xenobiotic canplay aroleinhypersensitivity, as shown inTable
2. Some lowmolecularweightcompoundsaresensitizers, inthat
an immune responsedevelopstothecompound, perhaps incon-
jugated form to endogenous proteins. Well-known examples
from the study ofoccupational asthma include toluene diiso-
cyanate (10), platinum salts (11), andtrimelliticanhydride (12).
IgEproduction againstthematerialshavebeendemonstrated in
somecases, butinallcasestheclinicalresponse isthesame, with
an initial exposure followed by sensitivity on reexposure.
Environmental adjuvants are compounds that enhance or
potentiatetheimmuneresponsetoasecond substance. Concur-
rent exposure to an environmental adjuvant and a second
substance, most commonly a protein aeroallergen, leads to an
immune responsemountedtowardthesecond substance. Table
3 lists some demonstrated environmental adjuvants and the
related allergens from animal models.
Tosufferfromahypersensitivitydisorder, itisnecessarybut
not sufficient to manufacture IgE against an environmental
substance. One must also have a responsive target organ. Ifa
groupofpeoplewhomakeIgEagainstchickeneggproteinwere
fedeggs, somewouldgethivesorgastrointestinal symptoms, and
a few might have rhinitis or asthma from the exposure, dem-
onstratingatargetorganintheskin, gastrointestinal tract, nose,
or lungs, respectively. Another group would remain asymp-
tomatic because they do not have a responsive organ. Our
knowledgeofthemechanismsby whichoneacquiresarespon-
siveorgan toimmediatehypersensitivity reactionsis scant, but
theinductionofbronchialhyperactivityinthehumanlungbyex-
posure to organic chemicals has been reported (13).
With the incidence of asthma increasing in industrialized
societies(14), itisimportantthattherelationshipbetweenVOCs
and asthma be studied. Depression is also increasing in recent
Table3. Examples ofenvironmental adjuvants.
Species Environmental adjuvant Allergen Reference
Guineapig Sulfurdioxide, ozone, and Ovalbumin (18)
nitrogen dioxide
Guinea pig Sulfurdioxide Ovalbumin (19)
Monkey Ozone Platinum (20)
Mouse Diesel exhaustparticles Japanese cedar (21)
pollen
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Tible 4. Chemically sensitivegroups.
Group Nature ofexposure Demographics
Industrial workers Acute and chronic exposure to industrial chemicals Primarily males; blue collar; 20-65 years old
Tight building occupants Off-gassing from construction materials, officeequipment or Females morethan males; white-collar office workers and pro-
supplies; tobacco smoke; inadequate ventilation fessionals; 20-65 years old; school children
Contaminated communities Toxic waste sites; aerial pesticide spraying; ground water con- All ages, male and female; children and infants may be affected
tamination; aircontamination by nearby industry; and other first or most; pregnant women with possible effects on
community exposures fetuses; middle to lower class
Individuals Heterogeneous; indoor air(domnestic); consumer products; 70-80% females; 50% 30-50 years old; white; middle to
drugs; pesticides upper-middle class and professionals
times, anddrmatically soamongtheyoung(15), anditisknown
thatpharmaceuticals caninducedepression andhallucinations
as side effects. Exposure to leaky furnace fumes has been
reportedinassociation withdepression (16). Therearereasons
tothinkthatothermentalillnesses mayberelated toVOCs, and
this area needs clarification with good clinical research.
ClinicalresearchtostudytheroleofVOCsinhumandiseases
will requirea special clinical research unit in which indoorair
is as pure as technically possible. [For a discussion of En-
vironmental Control Units including historical references, see
AshfordandMiller(17).]Individualswithknowndiseasessuch
as rheumatoid arthritis, lupus, asthma, and depression will be
housedinthisunitandmonitoredforimprovementoftheirsymp-
toms. Ifthere is improvement, subjects will be reexposed in a
double-blinded fashionandmonitored forexacerbations. Such
aprogramwillbeexpensive, butifthehypothesisthatVOCs in-
duce orexacerbate humandiseases is sustained, the savings in
health care costs will beenormous. More importantly, the im-
provedqualityoflifeandalleviationofsufferingthatcouldresult
is priceless.
Multiple Chemical Sensitivity
Muchofthefollowing discussionisdrawnfromAshfordand
Miller(22). Theproblemsthatpresentthemselvesaschemical
sensitivity seem to occur in at least four identifiably different
clustersofindividuals (Table4) (22). Weseetheseproblems not
onlyamongtight-buildingoccupants (categorytwo), butalsoin
occupational settings (category one), andincontaminated com-
munities (category three) that are downwind from a chemical
plant or in places like Love Canal orWoburn, Massachusetts.
Therearealsoapotpourriofindividuals with acomplexhistory
ofexposureswhoendupgoing tomanyphysicians with asetof
multiplecomplaintsthatareyettobefully understood (category
four).
Itisworthnotingthatthedemographicsofthesegroupsofpeo-
pleareverydifferent. Theoccupationaldemographics, fromthe
peoplewholiveincontaminatedcommunitiesandfrompeople
who live or work in tight buildings, the age, sex, and social
characteristics ofaffectedindividuals seemquitedifferent. The
similarities anddifferences among these groups will eventual-
ly elucidatethisproblem.
Itisimportanttodistinguishdifferentconceptsofsensitivity.
In Figure 1 the percent of a population first exhibiting some
definedharmfuleffectversusthedoseatwhichitisobserved is
plotted. Thereareatleastthreedifferentcurvesthatcanbecon-
structed. One is curve A, which represents a classical toxic
effect-liketheexposuretolead. CurveAdepicts aratherbroad
distribution ofdoses at which different people respond to the
classical toxic substance. Some people respond at much lower
levels than the norm and are in the tails ofthe distribution. We
tend todefinethesepeopleassensitivepeople. Thepeoplewho
are attheotherendandintheothertail wecall resilientpeople.
Everybody, sooner or later when they are exposed to lead, ex-
hibits acertainparticularneurologicalendpointortoxicological
endpoint. Thosewhorespondatlowdoses wecall "sensitive."
Classicaltoxiceffectsaredifferentfromallergyoratopy(curve
B) where a group ofpeople suffer from pollen allergies or in
some cases from immunologically mediated sensitivity to
chemicalssuchastoluenediisocyanate(TDI). Buthereitisclear
that 100% ofthepeoplewill notbeaffectedattheconcentrations
ofpollenorTDIeverlikelytobefoundintheenvironment. Thus
wecall theentiredistribution a "sensitivepopulation"; this is a
different concept ofsensitivity.
Finally, wehave anemergingproblem that weare struggling
tounderstand, multiplechemical sensitivity, whichappearstobe
amorecomplexprocess. Whatseemstoberequiredisasensitiz-
ing event, very often to ahigh level oftoxic material, followed
thereafter by a reaction triggered at flow levels ofexposure to
chemicals-much lowerthanthatobserved inthecontextofor-
dinarytoxiceffects. CurveC isahypotheticaldistributionofone
suchtriggering eventinasensitizedpopulation. Thesensitizing
eventorprocess, whichmayaffecttheimmunesystem, thelim-
bicornervoussystem, orenzymedetoxification, maybeinfact
somekindofclassical toxiceffectthatwehaveyettounderstand.
Butonce individuals are sensitized, thetriggering mechanism is
notexplained by ordinary toxicology as we know it.
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FIGURE 1. Hypothetical distribution of different types of sensitivities as a
functionofdose. CurveA isasensitivitydistributionofclassical toxicity, e.g.,
toleadorsolvent. Sensitive individualsare found intheleft-handtailofthe
distribution. Curve B is a sensitivity distribution ofatopic or allergic in-
dividuals inthe population who are sensitive to an allergen, e.g., ragweed
orbeevenom. CurveCisasensitivitydistributionofindividualswithmultiple
chemicalsensitivities who,becausetheyarealreadysensitized, subsequently
respond to particular incitants, e.g., formaldehyde orphenol.
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FIGURE 2. Hypothetical population dose-response curves for different ef-
fecs. CurveA isacumulativedose-response curve forclassical toxicity, e.g.,
to lead orasolvent. CurveBisacumulativedose-responsecurve foratopic
orallergic individuals inthepopulationwhoaresensitivetoanallergen, e.g.,
ragweedorbeevenom. Curve Cisacumulativedose-responsecurveforin-
dividuals with multiple chemical sensitivities whobecausethey arealready
sensitized, subsequently respond toparticularirritants, e.g., formaldehyde
orphenol.
Table 5. Observations concerning multiple chemical sensitivity.
Symptoms involving virtually any system ofthebody orseveral systems simul-
taneously
Differing symptomsandseverity indifferent individuals, eventhosewiththesame
exposure
Induction (i.e., sensitization) by a wide rangeofenvironmental agents
Subsequent triggering by lowerlevels ofexposurethan those involved in initial
induction ofthe illness
Concommitant food intolerances, estimated tooccur in a sizable percentage of
those with chemical sensitivities
"Spreading" ofsensitivity toother, oftenchemicallydissimiliar, substances. Each
substance may trigger adifferent constellation ofsymptoms.
Adaptation (masking), i.e., acclimatization to environmental incidents, both
chemical and liod, withcontinuedexposure; lossofthistolerancewith removal
from the incident(s); and augmented response with re-exposure after an ap-
propriate interval (e.g., 4-7 days)
An apparent threshold effect referred to by some (including certain tradional
allergists) as the patient's "total load"
Justas when webegan to recognize thatcancer is a two-step
process (at least), initiation and then promotion, and a full
understanding ofcancer could not be appreciated with the or-
dinary toxicological model, here too the processes that are
underway mustbefully understoodtoappreciatewhatchemical
sensitivity is. A failure to define the problem of multiple
chemical sensitivity has been largely due to the failure to
acknowledge the differences in the different concepts of
sensitivity.
In Figure 2, if we plot the number of people affected in a
cumulative fashion, we have the more familiar dose-response
curves, withclassical toxicitylevelingoffat 100% ofthepopula-
tionaffected, andmultiplechemical sensitivity levelingoffsome
placedifferent. Not 100% ofthepeoplearesensitiveorhavebeen
sensitized and not 100% will respondat those low levels.
In Table5, wehave adescription ofwhat it is thatphysicians
andobserverscallthechemically sensitivepopulation. Wehave
tobeable toexplainall thesecharacteristics someday ifweare
going togetahandleontheproblem. First, thesymptoms seem
to involve virtually any system in the body or several systems
simultaneously. Second, thereareavarietyofsymptomsdiffer-
ing in severity in different individuals, even in those with the
same exposure. This is hard to explain with a simple dose-
responseconcept. Third, induction isobservedbyawide range
ofenvironmental agentsmost frequently found with pesticides
andsolventsexposure. Fourth, thereisasubsequenttriggering
ofchemical sensitivity bylowerlevelsofexposurethanthose in-
volved intheinitial inductionofthedisease (the second stepof
a two-step process).
Fifth, concomitantfoodintoleranceisestimatedtooccurina
sizablepercentageofthosewithchemicalsensitivities.Wemaybe
observing a cross-reactivity with food, e.g., as in the case of
toluenediisocyanateandradishes. Foodsensitivitiesandchemical
sensitivitiesmaynotbeallthatunrelated. Sixth,thereseemstobe
a spreading of sensitivity to other chemically dissimilar sub-
stances. Seventh, adaptationormaskingisakeyconcept: some
peoplewhoaretriggeredinitiallydonotseemtobetriggeredafter
continual exposure. This presents a formidable diagnostic
challenge. Ifapatientislookedatinakindofsaturated,adapted
state,aphysicianmaynotbeabletodiscoverthethingsthatthepa-
tienthasreportedinhisownhome. Finally,thereappearstobean
apparentthresholdeffecthavingtodowiththepatient'stotalload.
Eventuallyalltheseobservationswillhavetobeadequatelyex-
plainedifothersaretobeconvincedthattheproblemisreal.
Adaptationisthekeytounderstandingchemicalsensitivity. It
ischaracterizedbyatoleranceafterrepeatedexposurethatresults
in a masking of symptoms. Adaptation makes it difficult to
discovertheeffectsofaparticularexposureonthebody. Further
exposures may have little impact and therefore effects are not
observed. Thisiswhyyouneedanenvironmentalunitinwhich
people are housed and de-adapted to discover the range and
natureoftheresponsetochemicalsorfoods. Chemicalexposure
may adversely affect adaptive mechanisms thus leading to ill-
ness. Itmaybethatthis wholeproblem is relatedtoamaladap-
tation insomeindividuals; thusadaptation isextremely impor-
tantto understand and research.
Insteadofsearchingforanarrowcasedefinitionforchemical
sensitivity by finding a physiological marker or biological
marker, forresearchpurposesatthisstage, itisbettertobeem-
pirical andto focus onthe notionthatthepatientwith multiple
chemical sensitivities can be discovered by removal from the
suspected offending agents and by rechallenge after an ap-
propriateintervalunderstrictly controlledenvironmental con-
ditions (preferablydouble-blind, placebocontrolled). Causality
isinferredbytheclearingofsymptomswithremoval fromtheof-
fending environment and the reoccurrence of symptom with
specificchallenge. Ithastobedoneverycarefully,.becausede-
adaptedpeople may beextremely sensitive.
The mechanisms ofdamage arejust beginning to be under-
stood. It has been suggested that both physiological as well as
psychogenic mechanisms may be at play. Some of the phys-
iologicalmechanismsthathavebeensuggestedarethe nervous
system, particularly involving the limbic system, the immune
systemsandenzymedetoxification. Itiscrucialthatwenotcon-
fusepresentationofpsychological symptomswithpsychogenic
causes. Chemicals are known to havepsychological sequelae.
Becausepeoplehavecentralnervoussystemproblemsdoesnot
meanthatthereisapsychological orpsychogenicoriginofthat
problem. Onehastoseparatethepresentationofsymptomsfrom
the origin of the condition; pursuing a psychogenicet
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iology maybemisguidedwithoutfirsteliminatingenvironmental
causes. The environment unit is essential for thistask.
Fromtheperspectiveofstrategies, forresearch weneedtoad-
vancethetheoryofcausationatlow levels. Wehavetounderstand
thistwo-stepprocessofinductionandtriggering, andweneedto
be able to compare the groups that seem to be exhibiting these
problems to understand the nature of the problems. Tight
buildings arecharacterizedbyauniquefeature: oftenthereisan
event involving auniqueexposureafterwhichpeopleseemtobe
sick. Wecan follow thedevelopment ofillnessesand symptoms
over time after an initiating event.
Weneedtoadvancetheanalytical techniques forexposure, for
susceptibility, and for health effects. There is a need for bi-
omarkers, but we may not be able to get biomarkers forlimbic
system damage. Those markers are unlikely to be found in the
bloodstream.
Finally, we need to advance epidemiology of exposure to
chemicals wherewehavenotonlymultipleexposures, butmulti-
ple symptoms that mightbe unconnected in analysis ofdisease
without an underlying mechanism.
Thechallenges presented by multiplechemical sensitivity re-
quire painstaking approaches. A public health problem ofin-
creasing dimensions demands this attention.
Biological Markers of Susceptibility
Molecularbiology isbeginningtosubstantiatewhatbiologists
have observed since Darwin's time, which has been subsumed
undertheconcept of"populationthinking." Thatis, tothinkof
populations in terms of averages glosses over the extensive
heterogeneity and variability within populations. This has im-
plications forthestudy ofcontemporary buildingenvironments.
This heterogeneity andvariability needstobetakenintoaccount
in these studies. With that prerequisite, biological markers of
susceptibility can be potentially useful in these studies.
There areboth methodologic andsocietal aspectsthatshould
beconsideredwhenthinkingaboutmarkersofsusceptibility. The
methodologic aspects arethat indeveloping studies ofpopula-
tions who work in buildings or who live in various kinds of
residential configurations. Studiesneedtoincludethesekindsof
indicators ofsusceptibility. Theword "susceptibility" isanemo-
tionally polarizing term, and Ipreferto use theepidemiologic
concept of "effect modifier." In other words, why do some
subsetsofapopulation experienceaneffectwhenothersdonot.
This istreated inepidemiologic researchas an effect modifier.
To account for this extensive variability (and a lot of it is
genetic) weshouldconsiderothercharacteristics ofhostfactors
thatpertaintotheexperiencesthatpeoplehavehadintheirlives.
Wealsoneedtohavedesignsthataccountfortheothernonhost
factorsthatmightresultinapotentialhealtheffect. Theseother
factors includesuchthingsinanenvironmentaslight,sound, and
the social relations that go on among people who work within
thesestructures. Toconsiderthisasjustanindoorairqualitypro-
blem misses some ofthekinds ofwide, ranging aspects ofthe
problem. Hence, itisimportantnottojustthinkofthisasanin-
doorairproblem, butasaproblemofcontemporarybuilding en-
vironments. Todothat, we need multidisciplinary teams. This
conference isagoodfirststep. Itbringstogetherapartial range
of the disciplines involved, but not nearly as many of the
disciplines that should be brought to bear on this problem. In
termsofthemethodologiesused, wehavetoputmuchmoreem-
phasisontheuseofmultivariate statisticalmodelstotrytoincor-
poratethewiderangeofcharacteristicsthatareinvolvedinthese
kindsofproblems. Thisisnotonlyanepidemiologicalquestion,
itisalsoaquestionthathastobringtogetherepidemiologyand
toxicology. We have to have a better working relationship be-
tweenpeopledoingtheanimalstudiesandpeopledoingthefield
studies. We do nothavethatat this time.
Ifwearetoconsidermarkersofsusceptibility asindicatorsof
effectmodification instudiesofbuildings andcontemporary en-
vironments, weneedtosetupasocietalframeworktoallowthat.
Rightnow wedonothavethatsocietalframework. Oursociety
doesnothaveagoodtrackrecordindealingwithindividualdif-
ferencesandwehaveseenthatintermsofhowsocietydealswith
differentraces,howitdealswithpeoplewithhandicaps, andeven
how itdealswithtalentedpeople. Weraisetalentedpeopleupand
discriminateagainstpeoplewithhandicaps. Wetakepeoplewho
aredifferentandtreatthemunfairly. Wehavetostarttocometo
asocietal consensusonhowwearegoingtodealwithindividual
differences. Wedonothavethatconsensus. Wedonotevenhave
atthisconferencethekindofpeoplewhocan initiatethatkindof
discussion.
Ifwe are going to start using molecular biological assays to
detectsubtledifferencesbetweenpeople, wehavetohavesome
sortofsocietalunderstanding ofhowwearegoingtorespondto
thosedifferences. Howarewegoingtotreatthepeoplewhohave
thosedifferences? Howwillweprotecttheirrights?Howwillwe
protect them from discrimination? Wedo not have thatkind of
societal understanding atthispoint.
Consequently, itisdifficult fortheresearchtobesanctioned
toallowustostarttolookatthekindsofgeneticvariabilitythat
may well impacton whogetsaneffectand whodoes notgetan
effect in a particular environment. My message is, we have to
haveabroadergroupofpeoplebroughttobeartoaddressthese
kinds ofproblems.
Case Study: Past and Present State
Program Priorities
Overthepastdecade, publichealthofficials haveexperienc-
ed a steady rise in citizen acute heath complaints attributed to
residentialandcommercialindoorenvironments (23). Initially,
the combination ofincreased energy efficiency demands with
new construction and consumer products material technology
was implicated as a critical factor explaining much ofthe in-
crease. The early investigations provided us with a better
understandingofthefragilityoftheindoorenvironment. Often,
only anarrowmarginexistedbetweentypical concentrations of
pollutants andthelevelatwhichacuteirritationoccurredamong
asignificantproportion ofexposed individuals.
Towhatextentexposuresbelowirritant/odorthresholds may
contributetochronicdisease isthefocusofresearcheffortsand
riskassessment. Seeminglyinconsequentialphysicalchangesto
the indoor environment can have significant public health
impacts.
A second element that surely contributed to the increase in
citizencomplaintsisbestdescribed asaloweringofthepublic's
discomforttolerance. Fordecades environmental tobacco smoke
(ETS) was known as themostcommon indoorairpollutant. It
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wasjustas irritating in the past as it is today. Instead ofmasking
unpleasant odors with agreeable ones as many air fresheners do,
ETS masked other agents with unpleasant odors and effects. For
years the public identified the ETS, but appeared prepared to
tolerate its aggravation. Today, the majority of people are not
prepared to continuetolerating that level ofirritation. The iden-
tificationofserious chronic disease risks associatedwith ETS has
hastened its rejection and led to an increase in clean indoor air
legislation.
With ETS removed from more and more work areas, other
agents, whose effects had been masked or overpowered by the
odor and irritation from ETS, became noticeable. These have
now become our second generation targets for evaluation. In ad-
dition to the removal ofETS from indoor environments, fewer in-
dividuals are smoking cigarettes, with the result that more peo-
ple have a rejuvenated sense of smell and are noticing indoor
pollutants. Indoor air specialists must now address complex
volatilechemical mixtures, "sickbuilding syndrome," and multi-
ple chemical sensitivity issues.
InWisconsin as well as in many health departments, an indoor
air program was first instituted to address acute, irritant com-
plaints related to formaldehyde off-gassing from foam insulation
and/or particle board used in mobile home construction (24).
Risk management decisions in the early 1980s significantly
reduced exposure to formaldehyde from these sources. Com-
plaints have been significantly reduced since the establishment
ofan industry-wide product standard.
Most state health programs have been unable to break out of
the "reactive epidemiology" mode of only having sufficient
resources to selectively conduct complaint investigations. This
means that priority is placed on agents causing acute irritant
symptoms.Priorities reflect constituency concerns anddemands,
notthepublic health or scientific assessmentofcomparative risk.
Historically, the priority given to complaints has left few
resources to implement more "proactive" epidemiologic pro-
grams. Priorities have been driven by acute health effects rather
than perhaps more serious chronic disease concerns. Few state
health programs are able to devote effort to identifying and in-
vestigating potential new products/agents as problem exposure
sources before consumers begin to complain. Agents that do not
result in symptomatic complaints are likely to be given little at-
tention even though they may have important adverse health im-
pacts. Questions such as What are the health consequences ofthe
new high efficiency furnaces which no longer require chimneys?
and What are the impacts ofthe new synthetic carpet materials
with their antistain treatments? need to be answered.
Risk assessment has been most useful in evaluating chronic
health risks and could beused toorderprogrammatic priority by
severity ofrisk for such agents as environmental tobacco smoke,
radon, lead, and asbestos. How to use risk assessment for the
acute, irritant effects most commonly reported from indoor en-
vironments and compare results to chronic disease risk estimates
remains more problematical. Its application to all indoor air
pollution issues should help renew attention to the "old standbys"
ofindoorairpollution: lead, house dust allergens, and humidity.
Assessment ofindoor environments and their potential health
effects is growing in complexity. It is time to evaluate the existing
state and federal program priorities. Risk assessment can be a
useful tool in that process.
CaseStudy: Wood SmokeandChildren
An increasing number offamilies in the United States are elec-
ting to heat theirhomes with wood. Estimates indicate that over
1,000,000 new woodburning stoves (WBS) are sold fordomestic
use in the United States each yearandthatusage is increasing in
allsocioeconomic groups (25,26). Thethree basictesofWBS
are free-standing, fireplace insert, and furnace add-on units.
Documented hazards associated with their use include ac-
cumulation ofcarbon monoxide as well as an increased number
ofburn injuries and fires (27,28).
Different types ofWBS vary in quality and efficiency. How-
ever, even the most efficient WBS emit some hazardous pol-
lutantsdirectly into the home whenthe stove is operating andthe
door is opened to add wood (25,29-34). This issue is especially
important whenoneconsiders thetrendto increase home insula-
tionand overall airtightness in an effort to conserve energy and
reduceheat loss (27). Therefore, questions arise regarding possi-
ble health effects from exposure to byproducts of wood
combustion.
Two recent studies haveexplored theoccurrenceofrespiratory
problems inyoung children from homes heated with WBS in the
United States. The first was a prospective study in Michigan of
62 young children (31 fromWBS-heated homes and 31 controls
from homesheated by conventional means) matched forage, sex,
and place ofresidence (to control forthe potentially confounding
effects ofthese variables) from 1980 to 1985. Principal outcomes
assessed were chronic respiratory symptoms and acute chest il-
lness; related outcomes were duration of acute illness and
hospitalization forseverechest illnessbefbre age2 years (35-37).
The second was acase-control study in Arizona in 1988 of58
pairs ofAmerican Indian children matched for age (2 weeks-2
years) and sex. The children were stratified at selection by the
presence oflower respiratory tract illness (LRTI) and followed
backward intimetodetermine thedistribution ofexposures (38).
Findings forthe Michigan study indicated that the occurrence
of chronic respiratory symptoms and acute chest illness were
significantly greater for children from homes heated withWBS.
In addition, the duration of acute chest illness was two times
greater, and the number ofhospitalizations for severe chest il-
lness before 2 years ofage was 67% greater than for controls.
Findingsfor the Arizona study indicated thatWBS exposure
was a significant risk factor for LRTI in young children. The
calculated odds ratio was 4.9, with 95% confidence interval
boundaries of 1.7 to 12.9.
The Michigan study assessed a number offactors potentially
associated with the respiratory outcomes ofinterest, including
socioeconomic status, medical history, frequency ofphysician
visits, useofhumidifiers andairfilters, and useofother sources
of indoor air pollution associated with the occurrence of
respiratory problems in young children (i.e., parental smoking,
cooking with gas, and ureaformaldehyde foam insulation). The
Arizona study assessed medical history, humidifier use, parental
smoking, presence ofpets in the home, having more than peo-
ple in the home, having a, one-room home, absence ofrunning
water, and having a dirt floor.
None ofthe potentially confounding variables assessed in the
Michigan study were found to significantly affect differences in
outcomes between study and control groups. In the Arizona
study, the effect ofWBS exposure was found to be independent
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ofother factors, including recent respiratory illness exposure,
whichwastheonlyotherfactorsignificantlyassociatedwithLRTI.
Oneotherstudyhasinvestigatedrespiratoryeffectsofexposure
to WBS. The study subjects were elementary school children
uptothesixthgradefromWesternMassachusetts.Although64%
ofchildrenfromhomesheatedwithWBShadatleast one acute
respiratoryepisodeand22.5% hadatleasttwoepisodes,occur-
renceincontrols was notfoundtobesignificantlydifferent(39).
If exposure to WBS is associated with the occurrence of
respiratory symptomsandchestillness, as currentfindings sug-
gest, thenitremains todeterminewhich aspectsofWBS use may
beinvolved. IndoorheatingwithWBS can generate asignificant
amount of air pollution. Documented pollutant emissions of
WBSincludecarbonmonoxide,nitrogendioxide, sulfurdioxide,
respirableparticulates,aldehydes,polycyclicorganiccompounds,
benzo[aJpyrene, elemental carbon, and a variety of priority
pollutants and elements found in priority pollutants (such as
aluminum, calcium, potassium, sodium, sulfur, and silicon)
(25,29-34).
Respiration of these compounds could reasonably com-
promisetheciliatedepithelial cells, which are asignificant com-
ponent ofthe immune system throughout the tracheobronchial
tree. Therespiratory effectsofsuch exposure wouldprobablybe
greatest on the smaller, developing airways of young children
whoarelargelyconfinedwithinthehomeduringwintermonths.
Anumberofotherfactors mayalsoaffectindoorairpollution
andpotential respiratory effects fromheatingwithWBS. These
include peak versus average exposure, typeofWBSandlocation
withinthehome, typeandamountofwoodburned,degreeofair
tightnessandvolumeofthehome, reintroduction ofventedemis-
sions, temperaturefluctuations inwood-heated homes(as com-
pared tohomes with athermostat keeping indoortemperatures
in afairly narrow range), andlowindoorhumidity (especially at
night when WBS use is greatest for indoorheating).
DatafromtheMichiganandArizonastudiesdonotsupport an
association betweenthe occurrenceofrespiratoryproblems and
the typeofWBS, location withinthehome, or amountofwood
burned. It may be that respiratory responses to WBS exposure
may best fit a model of threshold response rather than dose
response, which wouldexplain the lackofcorrelation between
frequency of outcomes and amount of wood burned in the
Michigan study.
Positive findings from twoofthree independent studies sug-
gestthatepidemiologic assessmentofrisks fromindoorheating
able6. Distribtionofcompoundsinthegasphaein garettemainstream
smoke (MS) and sidestream smoke (SS), nonflterciprettes.
Gasphase MS SS/MS
Carbon monoxide 10-23 mg 2.5-4.7
Carbondioxide 20-60mg 8-11
Formaldehyde 70-100 pIg 0.1-50 (?)
Acrolein 60-100 Ag 8-15
Acetone 100-250 1pg 2-5
Pyridine 20-40 ug 10-20
3-Vinylpyridine 15-30 ;&g 20-40
Hydrogencyanide 400-500;Mg 0.1-0.25
Nitrogenoxides 100-600 Mg 4-10
Ammonia 50-130 ug 40-130
N-Nitrosodimethylamine 10-40 Mg 20-100
N-Nitrosopyrrolidine 6-30 Mg 6-30
with WBS should be pursued. The two studies focusing on
young children had significant findings, whereas the study
focusing on older children did not. No studies have been con-
ductedforadults. This suggeststhatthemostusefulinformation
would comefromprospectivestudiesthatincludedifferent age
groupsandacquire asmuchinformation aspossibleonWBSand
home parameters, pollutant levels, and respiratory outcome
measurements. Futureepidemiologic studies addressing these
areas should significantly contribute to our understanding of
respiratory risks from indoor heating with wood.
Case Study: Environmental Tobacco
Smoke
The major focus of this section is on the use of a specific
nicotine metabolite, cotinine, as a biomarker ofETS uptake.
Morethan4000compounds arepresentintobaccosmoke. Table
6summarizes thepredominantcompoundsthathavebeeniden-
tifiedinthe vaporphase. Ontherightofthetable, sidestream to
mainstreamsmokeratioshavebeentabulated. Table7provides
similar data for the main compounds found in the particulate
phase oftobacco smoke (40).
ToquantitatetheuptakeofETSinclinicalstudies, asensitive
andspecificbiomarkerisneeded.Themostextensivelyusedin-
dicatorofexposureiscotinine,whichisfoundinavarietyofbody
fluids. Cotininehasbeenquantitatedsuccessfullyusingseveral
methods. Atpresent,thetwomostcommonlyusedmethods are
gas chromatography and radioimmunoassay. More recently,
highly sensitive gas chromatographic/mass spectrometric
methods(GCIMS)havebeendevelopedthathavethepotentialto
accuratelyquantitatecotinineinthelow nanogram range.
Urine cotinine was quantitated by radioimmunoassay in the
studiesdescribedbelow. Thismethodhasseveraladvantages. It
isbothhighlysensitiveandspecificfortobaccosmokeexposure.
Becausethereisnoextractionstep,extractionlossiseliminated.
Thevolumeofsamplerequiredforanalysisisquitesmall(approx-
imately20jtLofplasmaand 10-20ltLofurine orsaliva). The
method has some disadvantages. The antibody cross reacts to
somedegreewithothernicotinemetabolitesthatmaybepresent
inurine, specifically, 3-hydroxycotinine.
Iwouldliketobrieflysummarize twostudies wherecotinine
measurements wereusedtoquantitateETSuptake. Thefirstis
anexperimental chamberstudy. Sixnonsmokers wereexposed
Table 7. Distribution ofcompo_un in the particulate phase in cigarette
mainstream smoke(MS)andsidestreamsmoke(SS), nonfiltercigarettes.
Particulatephase MS SS/MS
Particulate matter 15-40mg 1.3-1.9
Nicotine 0-2.3 mg 2.6-3.3
Phenol 60-120ug 2.0-3.0
Catechol 100-280Ag 0.6-0.9
Aniline 360 ng 30
2-Toluidine 160 ng 19
2-Naphthylamine 1.7 ng 30
Benz4aJanthracene 20-500 ng 24
Benzo[alpyrene 20-0 ng 2.5-3.5
N'-Nitrosonorrnicotine 200-3000 ng 0.5-3
NNK 100-1000ng 1-4
N-Nitrosodiethanolamine 20-70 ng 1.2
Nickel 20-80 ng 13-30
Polonium-210 0.03-0.5 pCi
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FIGURE 3. Urinary cotinine elimination in smokers and in passively expos-
ed nonsmokers. Urinary cotinine concentrations are nornalized by crea-
tinine.
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FIGURE 4. Placeofexposure. Domestic versus work exposuretoETS in male
and female municipal workers. The heightofeach bar is equal tothe mean
urinary cotinine (±SEM) foreach group. Mean urinary cotinine is plotted
versus domestic exposure, work exposure, domestic or workexposure, and
no exposure, for both men and women.
toETS generatedbycommercial cigarettes. Urinecotininelevels
were determined from daily measurements over the following
230hr. Maximumurinaryexcretionofcotininewasnotedatap-
proximately24hrafterexposure (Fig. 3). Usingthesedata, we
determined the rate ofcotinine elimination (tl/2B) in exposed
never-smokers. We then compared this approximate cotinine
eliminationratewiththatofanumberofactivesmokerswhoabs-
tainedfrom smoking forasimilarperiod. Weobservedasignifi-
cant decrease in the rate of cotinine elimination in never-
smokers whencompared tosmokers. Theprolongedelimination
and likely slower metabolism in nonsmokers suggests that
passively exposed individuals may alsocarry abody burden of
othertoxic tobacco smokecomponents for longerperiods than
smokers themselves (41).
Thesecondstudy isfromametabolicepidemiologicperspec-
tive. Werecruitedapopulation ofmunicipal workers fromtheci-
ty ofDallas, Texas, that consisted of 148 men and 112 women.
Bothmenandwomenwerebetween 35 and40yearsofage. We
asked these individuals to fill out a questionnaire ofperceived
ETS exposure and obtained a random urine sample from each
participant. Significant increases in urine cotinine concentra-
tions were observed in those volunteers who responded affir-
matively tothequestionsofsocialexposure, exposure intransit,
andat homeexposure (42).
Usingaqualitativescale(1 = noexposureand4 = heavy ex-
posure), wewereabletocorrelateperceivedexposurewithurine
cotinineconcentrations andto show thatmostexposure to ETS
occurs inthedomesticenvironment(Fig. 4). Thesestudies and
others canyield importantdataregardingperceivedexposurein
nonsmokersexposedtotobacco smoke. Theuseofcotinineasan
objective marker strengthens epidemiological studies that rely
on subjective or questionnaire data on ETS exposure.
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